The Prevalences of Diabetic Retinopathy and Nephropathy Are Lower in Type 2 Diabetes with Non-Alcoholic Fatty Liver Disease

被引：0
|
作者：
Kim, Bo-Yeon [1 ]
Kim, Kyu-jin [1 ]
Jung, Chan-Hee [1 ]
Mok, Jioh [1 ]
Kim, Chul-Hee [1 ]
Kang, Sung-koo [1 ]
机构：
[1] Soonchunhyang Univ, Bucheon Hosp, Sch Med, Bucheon, South Korea
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-1018
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes
    Seo, D. H.
    Lee, Y-H
    Park, S. W.
    Choi, Y. J.
    Huh, B. W.
    Lee, E.
    Huh, K. B.
    Kim, S. H.
    Cha, B-S
    [J]. DIABETES & METABOLISM, 2020, 46 (05) : 362 - 369
  • [32] Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes
    Afarideh, Mohsen
    Aryan, Zahra
    Ghajar, Alireza
    Ganji, Morsaleh
    Ghaemi, Fatemeh
    Saadatagah, Seyedmohammad
    Heidari, Behnam
    Mechanick, Jeffrey
    Esteghamati, Alireza
    [J]. PRIMARY CARE DIABETES, 2019, 13 (06) : 505 - 514
  • [33] Cardiorespiratory fitness in patients with type 2 diabetes and non-alcoholic fatty liver disease
    Afolabi, P. R.
    Scorletti, E.
    Calder, P. C.
    Byrne, C. D.
    [J]. DIABETIC MEDICINE, 2020, 37 : 45 - 45
  • [34] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bawany, Muhammad Adnan
    Lashari, Naveed Aslam
    Soomro, Majid Ali
    Memon, Hamid Nawaz Ali
    Laghari, Fiza
    Irshad, Muntaha
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (07): : 6283 - 6286
  • [35] Non-alcoholic fatty liver disease, sleep behaviors, and incident type 2 diabetes
    Zhang, Haojie
    Wang, Yuying
    Chen, Chi
    Wang, Bin
    Chen, Jie
    Tan, Xiao
    Xia, Fangzhen
    Zhang, Jihui
    Lu, Yingli
    Wang, Ningjian
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (08) : 1633 - 1640
  • [36] Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2
    Koullias, Emmanouil S.
    Koskinas, John
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (05) : 965 - 971
  • [37] Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease
    Fan, Hui
    Pan, QingRong
    Xu, Yuan
    Yang, XinChun
    [J]. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2013, 57 (09) : 702 - 708
  • [38] Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
    Tziomalos, Konstantinos
    Athyros, Vassilios G.
    Karagiannis, Asterios
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (02) : 162 - 172
  • [39] New perspective on type 2 diabetes, dyslipidemia and non-alcoholic fatty liver disease
    Matsuzaka, Takashi
    Shimano, Hitoshi
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (03) : 532 - 534
  • [40] Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes
    Bayliss, Jacqueline
    Ooi, Geraldine J.
    De Nardo, William
    Shah, Yazmin Johari Halim
    Montgomery, Magdalene K.
    McLean, Catriona
    Kemp, William
    Roberts, Stuart K.
    Brown, Wendy A.
    Burton, Paul R.
    Watt, Matthew J.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
12345